This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huber, P. E. Articles by Debus, J. Search for Related Content PubMed PubMed Citation Articles by Huber, P. E. Articles by Debus, J.

A New Noninvasive Approach in Breast Cancer Therapy Using Magnetic Resonance Imaging-guided Focused Ultrasound Surgery¹

Deutsches Krebsforschungszentrum (dkfz), Division of Radiation Oncology, D-69120 Heidelberg [P. E. H., J. W. J., R. R., I. S., J. D.]; Departments of Radiation Oncology [P. E. H., M. F. W., J. D.], Gynecology [H-J. S., D. V. F.], and Pathology [H-P. S.], University of Heidelberg Medical School, D-69120 Heidelberg, Germany

An ideal vision of modern medicine includes tumor surgery with the human body remaining completely intact. A noninvasive therapy could avoid infections and scar formation; it would require less anesthesia, reduce recovery time, and possibly also reduce costs. This study investigated whether human breast cancer can be effectively treated with a novel combination of image guidance and energy delivery, noninvasive magnetic resonance imaging (MRI)-guided focused ultrasound (FUS). We have developed a FUS therapy unit guided by MRI for the treatment of human breast tumors in a clinical 1.5 T MR scanner. With interactive target segmentation on MRI, defined volumes could be noninvasively treated in a single session with on-line MR temperature control. The ultrasound waves were focused through the intact skin and resulted in the localized thermal tissue ablation at a maximum temperature of 70°C. The therapy principle was first demonstrated in sheep breast in vivo and was then applied in a patient with core biopsy-proven invasive breast cancer 5 days before breast-conserving surgery. MRI proved suitable to delineate the breast cancer, served as stereotactic treatment planning platform, and delineated the FUS-related tissue changes such as interruption of tumor blood flow. Furthermore, MRI localized the hot spot in the tumor and measured temperature elevation during the treatment. This allowed us to monitor the efficacy and safety of FUS therapy. Immunohistochemistry of the resected specimen demonstrated that FUS homogeneously induced lethal and sublethal tumor damage with consecutive up-regulation of p53 and loss of proliferative activity. This effect was realized without anesthesia and damage to the surrounding healthy tissue or systemic effects. Overall, our results show that noninvasive MRI-guided therapy of breast cancer is feasible and effective. Thus, MRI-guided FUS may represent a new strategy for the neoadjuvant, adjuvant, or palliative treatment in selected breast cancer patients and in patients with other soft-tissue tumors.

This article has been cited by other articles:

				C. M. Tempany From the RSNA Refresher Courses: Image-guided Thermal Therapy of Uterine Fibroids RadioGraphics, November 1, 2007; 27(6): 1819 - 1826. [Abstract] [Full Text] [PDF]

				W. Hundt, E. L. Yuh, M. D. Bednarski, and S. Guccione Gene Expression Profiles, Histologic Analysis, and Imaging of Squamous Cell Carcinoma Model Treated with Focused Ultrasound Beams Am. J. Roentgenol., September 1, 2007; 189(3): 726 - 736. [Abstract] [Full Text] [PDF]

				G. Vlastos and H. M. Verkooijen Minimally Invasive Approaches for Diagnosis and Treatment of Early-Stage Breast Cancer Oncologist, January 1, 2007; 12(1): 1 - 10. [Abstract] [Full Text] [PDF]

				A Khiat, D Gianfelice, M Amara, and Y Boulanger Influence of post-treatment delay on the evaluation of the response to focused ultrasound surgery of breast cancer by dynamic contrast enhanced MRI. Br. J. Radiol., April 1, 2006; 79(940): 308 - 314. [Abstract] [Full Text] [PDF]

				M. A. Roubidoux, M. S. Sabel, J. E. Bailey, C. G. Kleer, K. A. Klein, and M. A. Helvie Small (<2.0-cm) Breast Cancers: Mammographic and US Findings at US-guided Cryoablation--Initial Experience Radiology, December 1, 2004; 233(3): 857 - 867. [Abstract] [Full Text] [PDF]

				M. Hashizume and K. Tsugawa Robotic Surgery and Cancer: the Present State, Problems and Future Vision Jpn. J. Clin. Oncol., May 1, 2004; 34(5): 227 - 237. [Abstract] [Full Text] [PDF]

				B. D. Fornage, N. Sneige, M. I. Ross, A. N. Mirza, H. M. Kuerer, B. S. Edeiken, F. C. Ames, L. A. Newman, G. V. Babiera, and S. E. Singletary Small ([Abstract] [Full Text] [PDF]

				N. McDannold, S. L. Fossheim, H. Rasmussen, H. Martin, N. Vykhodtseva, and K. Hynynen Heat-activated Liposomal MR Contrast Agent: Initial in Vivo Results in Rabbit Liver and Kidney Radiology, March 1, 2004; 230(3): 743 - 752. [Abstract] [Full Text] [PDF]

				C. M. C. Tempany, E. A. Stewart, N. McDannold, B. J. Quade, F. A. Jolesz, and K. Hynynen MR Imaging-guided Focused Ultrasound Surgery of Uterine Leiomyomas: A Feasibility Study Radiology, March 1, 2003; 226(3): 897 - 905. [Abstract] [Full Text] [PDF]